213 related articles for article (PubMed ID: 11726974)
1. SCAP ligands are potent new lipid-lowering drugs.
Grand-Perret T; Bouillot A; Perrot A; Commans S; Walker M; Issandou M
Nat Med; 2001 Dec; 7(12):1332-8. PubMed ID: 11726974
[TBL] [Abstract][Full Text] [Related]
2. A new feature on the cholesterol-lowering landscape.
Rader DJ
Nat Med; 2001 Dec; 7(12):1282-4. PubMed ID: 11726962
[No Abstract] [Full Text] [Related]
3. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
Abidi P; Zhang F; Li C; Liu J
Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
5. Genomic structure and chromosomal mapping of the human sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) gene.
Nakajima T; Hamakubo T; Kodama T; Inazawa J; Emi M
J Hum Genet; 1999; 44(6):402-7. PubMed ID: 10570913
[TBL] [Abstract][Full Text] [Related]
6. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
Kong W; Wei J; Abidi P; Lin M; Inaba S; Li C; Wang Y; Wang Z; Si S; Pan H; Wang S; Wu J; Wang Y; Li Z; Liu J; Jiang JD
Nat Med; 2004 Dec; 10(12):1344-51. PubMed ID: 15531889
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of human LDL receptor expression by SCAP ligand and cytokine oncostatin M.
Liu J; Zhang F; Li C; Lin M; Briggs MR
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):90-6. PubMed ID: 12524230
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.
Sekar N; Veldhuis JD
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor sterol regulatory element binding protein 2 regulates scavenger receptor Cla-1 gene expression.
Tréguier M; Doucet C; Moreau M; Dachet C; Thillet J; Chapman MJ; Huby T
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2358-64. PubMed ID: 15486308
[TBL] [Abstract][Full Text] [Related]
11. Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols.
Yabe D; Xia ZP; Adams CM; Rawson RB
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16672-7. PubMed ID: 12482938
[TBL] [Abstract][Full Text] [Related]
12. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
13. Effects of fibrillar C-terminal fragment of cleaved alpha1-antitrypsin on cholesterol homeostasis in HepG2 cells.
Janciauskiene S; Lindgren S
Hepatology; 1999 Feb; 29(2):434-42. PubMed ID: 9918920
[TBL] [Abstract][Full Text] [Related]
14. The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking.
Zhang J; Dudley-Rucker N; Crowley JR; Lopez-Perez E; Issandou M; Schaffer JE; Ory DS
J Lipid Res; 2004 Feb; 45(2):223-31. PubMed ID: 14617742
[TBL] [Abstract][Full Text] [Related]
15. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.
Yeh M; Cole AL; Choi J; Liu Y; Tulchinsky D; Qiao JH; Fishbein MC; Dooley AN; Hovnanian T; Mouilleseaux K; Vora DK; Yang WP; Gargalovic P; Kirchgessner T; Shyy JY; Berliner JA
Circ Res; 2004 Oct; 95(8):780-8. PubMed ID: 15388640
[TBL] [Abstract][Full Text] [Related]
16. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S
Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response.
Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Dorea EL; Bernik M; Hirata RD
Clin Chim Acta; 2008 Jul; 393(2):119-24. PubMed ID: 18435918
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
19. [SCAP: a polytopic membrane protein that modulates the sterol regulated cleavage of SREBPs].
Sakai J
Nihon Rinsho; 2001 Feb; 59 Suppl 2():270-6. PubMed ID: 11351587
[No Abstract] [Full Text] [Related]
20. CREating a SCAP-less liver keeps SREBPs pinned in the ER membrane and prevents increased lipid synthesis in response to low cholesterol and high insulin.
Osborne TF
Genes Dev; 2001 Aug; 15(15):1873-8. PubMed ID: 11485982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
